Literature DB >> 844675

The effect of cholecystokinin on human taenia coli.

E H Egberts, A G Johnson.   

Abstract

Superfusion of twelve human Taenia Coli strips with cholecystokinin (CCK) (boots and GIH Karolinska), CCK-octapeptide and glucagon at doses of 25--1,000 mIDu/ml evoked muscular contractions. Dose-dependent response to acetylcholine (ACH) (0.15--1.0 mug/ml) was not altered by an underlying contraction induced by CCK, CCK-octapeptide or glucagon. Though atropine (0.1 mug/ml) abolished ACH effects, hormonal responses were unaffected. The muscles' sensitivity was highest of CCK (Boots) and lowest to CCK-octapeptide, and the sigmoid colon was more sensitive than other parts of the bowel to both. Addition of glucagon had no effect on CCK-induced (Boots) responses. The results suggest (1) CCK and CCK-octapeptide act directly on the Taenia coli; (2) biologically active impurities in the whole CCK preparations explain their apparent increased activity; (3) glucagon does not block ACH or CCK, nor inhibit, directly, muscle contractions; (4) atropine (0.1) mug/ml)) does not interfere with CCK or CCK-octapeptide on colonic muscle.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844675     DOI: 10.1159/000198005

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  The effects of cholecystokinin octapeptide on human isolated alimentary muscle.

Authors:  M D'Amato; I F Stamford; A Bennett
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Effect of CCK-OP and intraduodenal administration of essential amino acids on intraluminal pressures of sigmoid and rectum in patients with Chagasic megacolon.

Authors:  J F Macedo; U G Meneghelli; R B Oliveira; R A Godoy; L E Troncon; R O Dantas
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

3.  Mechanism of action of cholecystokinin on colonic motility in isolated, vascularly perfused rat colon.

Authors:  Byeong-Seong Ko; Joung-Ho Han; Jee-In Jeong; Hee-Bok Chae; Seon-Mee Park; Sei-Jin Youn; Kae-Yol Lee
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.